Gene · 54795
Papers1,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A hydrophobic funnel governs monovalent cation selectivity in the ion channel TRPM5. | Biophys J | 2024 | 39086136 | PubTator, text mining | PubMed |
| Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4. | Cancer Res Commun | 2024 | 39041239 | PubTator, text mining | PubMed |
| In Silico Electrophysiological Investigation of Transient Receptor Potential Melastatin-4 Ion Channel Biophysics to Study Detrusor Overactivity. | Int J Mol Sci | 2024 | 38999984 | PubTator, text mining | PubMed |
| A frozen portrait of a warm channel. | Cell Calcium | 2024 | 38959762 | PubTator, text mining | PubMed |
| TRPM4 mRNA stabilization by METTL3-mediated m6A modification promotes calcific aortic valve inflammation. | Heliyon | 2024 | 38868032 | PubTator, text mining | PubMed |
| Role of the transient receptor potential melastatin 4 in inhibition effect of arsenic trioxide on the tumor biological features of colorectal cancer cell. | PeerJ | 2024 | 38854798 | PubTator, text mining | PubMed |
| TRPM4-Inspired Polymeric Nanochannels with Preferential Cation Transport for High-Efficiency Salinity-Gradient Energy Conversion. | J Am Chem Soc | 2024 | 38842082 | PubTator, text mining | PubMed |
| Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration. | J Allergy Clin Immunol | 2024 | 38750824 | PubTator, text mining | PubMed |
| Physiological temperature drives TRPM4 ligand recognition and gating. | Nature | 2024 | 38750366 | Swiss-Prot, curated | PubMed |
| Molecular genetic screening after non-ischaemic sudden cardiac arrest and no overt cardiomyopathy in real life: A major tool for the aetiological diagnostic work-up. | Arch Cardiovasc Dis | 2024 | 38670870 | PubTator, text mining | PubMed |
| Discovery of a polymorphic gene fusion via bottom-up chimeric RNA prediction. | Nucleic Acids Res | 2024 | 38587197 | PubTator, text mining | PubMed |
| Erythrokeratodermia Variabilis-like Phenotype in Patients Carrying ABCA12 Mutations. | Genes (Basel) | 2024 | 38540347 | PubTator, text mining | PubMed |
| Dilation of ion selectivity filters in cation channels. | Trends Biochem Sci | 2024 | 38514273 | PubTator, text mining | PubMed |
| Cardiac conduction disorders in young adults: Clinical characteristics and genetic background of an underestimated population. | Heart Rhythm | 2024 | 38467355 | PubTator, text mining | PubMed |
| Covalent organic framework based cytoprotective therapy after ischemic stroke. | Redox Biol | 2024 | 38442647 | PubTator, text mining | PubMed |
| Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. | Int J Mol Sci | 2024 | 38396898 | PubTator, text mining | PubMed |
| Sodium-Permeable Ion Channels TRPM4 and TRPM5 are Functional in Human Gastric Parietal Cells in Culture and Modulate the Cellular Response to Bitter-Tasting Food Constituents. | J Agric Food Chem | 2024 | 38378185 | PubTator, text mining | PubMed |
| High-throughput screening of transient receptor potential (TRP) channels in pterygium. | Int Ophthalmol | 2024 | 38347388 | PubTator, text mining | PubMed |
| In vivo evaluation of monoclonal antibody M4M using a humanised rat model of stroke demonstrates attenuation of reperfusion injury via blocking human TRPM4 channel. | J Drug Target | 2024 | 38345028 | PubTator, text mining | PubMed |
| An Investigation into the Relationship of SUR-1TRPM4 Receptor with Peritumoral Edema in High-Grade Glial Tumors. | Turk Neurosurg | 2024 | 38282587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54795/papers?page=8